EsoCap AG
Pharmaceuticals · Basel, Basel-Stadt
EsoCap AG is a Swiss pharmaceuticals company based in Basel, Canton of Basel-Stadt, listed in the Swiss commercial register since 2017 (UID CHE-467.535.992).
Board members & signatories
- Dr. Werner Tschollar — Präsident des Verwaltungsrates
- Dr. Jacques Gonella — Mitglied des Verwaltungsrates
- Christoph Hoffmann — Mitglied des Verwaltungsrates
Registered purpose
Die Gesellschaft bezweckt die Forschung, Entwicklung, Fabrikation und den Vertrieb im Bereich von pharmazeutischen, medizinischen, biotechnologischen und verwandten Produkten sowie die Erbringung von damit im Zusammenhang stehenden Dienstleistungen. Die Gesellschaft kann sich daneben an anderen Unternehmen irgendwelcher Art im In- und Ausland beteiligen, solche gründen, übernehmen und mit ihnen fu…
Source: Swiss commercial register (Zefix / SOGC) and Alpintel analysis · Data as of March 2026
What EsoCap does
OFFERING
EsoCap AG develops advanced drug delivery technologies specifically for esophageal diseases. Their lead candidate, ESO-101, is designed to improve treatment outcomes for eosinophilic esophagitis by ensuring therapeutic agents are effectively targeted to the esophagus, allowing for longer contact time with the drug. The company integrates various therapeutic modalities, including small molecules, peptides, antibodies, and liposomal encapsulated RNA into their film technology.
Unlock the full analysis →Similar companies
- Adagene AG — Pharmaceuticals · Basel
- AsedaSciences AG — Biotechnology · Schindellegi
- EMAGine AG — Pharmaceuticals · Zug
- AL-S Pharma AG — Pharmaceuticals · Schlieren
- Cimeio Therapeutics AG — Pharmaceuticals · Basel
- Bright Peak Therapeutics AG — Pharmaceuticals · Allschwil
Find every pharmaceuticals company in Switzerland
Alpintel searches all 710,000 Swiss companies with AI — filter by industry, size, revenue, region and ownership in seconds.
family-owned pharmaceuticals companies with 50+ employees…Search →Full profiles from CHF 49/month · Cancel anytime